Control of redox state and redox signaling by neural antioxidant systems

Antioxidants and Redox Signaling

Volumn 14, Issue 8, 2011, Pages 1449-1465

  Lewerenz, Jan ^a   Maher, Pamela ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; CYSTEINE; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE DISULFIDE REDUCTASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; GLYOXALASE; INITIATION FACTOR 2ALPHA; NITRIC OXIDE; PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; BRAIN NERVE CELL; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME REGULATION; ENZYME SYNTHESIS; GLUTATHIONE METABOLISM; HUMAN; NEUROLOGIC DISEASE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; UPREGULATION;

ANIMALS; ANTIOXIDANTS; CENTRAL NERVOUS SYSTEM; GLUTATHIONE; HUMANS; NEURONS; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 79952840767     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3600     Document Type: Review

References (202)

1. Adams CM. Role of the transcription factor ATF4 in the anabolic actions of insulin. J Biol Chem 282: 16744-16753, 2007.
2. Albrecht P, Lewerenz J, Dittmer S, Noack R, Maher P, and Methner A. Mechanisms of oxidative glutamate toxicity: The glutamate=cystine antiporter system x(c)- as a neuroprotective drug target. CNS Neurol Disord Drug Targets 9: 373-382, 2010.
3. Ameri K and Harris AL. Activating transcription factor 4. Int J Biochem Cell Biol 40: 14-21, 2008. (Pubitemid 350064577)
4. Arthur JR. The glutathione peroxidases. Cell Mol Life Sci 57: 1825-1835, 2000. (Pubitemid 32102578)
5. Avitahl N and Calame K. The C=EBP family of proteins distorts DNA upon binding but does not introduce a large directed bend. J Biol Chem 269: 23553-23562, 1994. (Pubitemid 24293556)
6. Bains JS and Shaw CA. Neurodegenerative disorders in humans: The role of glutathione in oxidative stressmediated neuronal death. Brain Res Rev 25: 335-358, 1997. (Pubitemid 28071452)
7. Baker DA, Zheng-Xiong X, Shen H, Swanson CJ, and Kalivas PW. The origin and neuronal function of in vivo nonsynaptic glutamate. J Neurosci 22: 9134-9141, 2002. (Pubitemid 35379084)
8. Ballatori N, Krance SM, Marchan R, and Hammond CL. Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology. Mol Aspects Med 30: 13-28, 2009.
9. Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, and Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 390:191-214, 2009.
10. Balogun E, Hoque M, Gong P, Killeen E, Green CJ, Foresti R, Alam J, and Motterlini R. Curcumin activates haem oxygenase-1 gene via regulation of Nrf2 and the antioxidantresponsive element. Biochem J 371: 887-895, 2003. (Pubitemid 36578887)
11. Bannai S and Kitamura E. Role of proton dissociation in the transport of cystine and glutamate in human diploid fibroblasts in culture. J Biol Chem 256: 5770-5772, 1981. (Pubitemid 11043456)
12. Barker JE, Heales SJR, Cassidy A, Bolanos JP, Land JM, and Clark JB. Depletion of brain glutathione results in a decrease of glutathione reductase activity; an enzyme susceptible to oxidative damage. Brain Res 716: 118-122, 1986.
13. Bateman RL, Rauh D, Tavshanjian B, and Shokat KM. Human carbonyl reductase 1 is a S-nitroglutathione reductase. J Biol Chem 283: 35756-35762, 2008.
14. Beher D, Wu J, Cumine S, Kim KW, Lu SC, Atangan L, and Wang M. Resveratrol is not a direct activator of Sirt1 enzyme activity. Chem Biol Drug Des 74: 619-624, 2009.
15. Bensadoun JC, Mirochnitchenko O, Inouye M, Aebischer P, and Zurn AD. Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice. Eur J Neurosci 10: 3231-3236, 1998. (Pubitemid 29070619)
16. Berk M, Ng F, Dean O, Dodd S, and Bush AI. Glutathione: A novel treatment target in psychiatry. Trends Pharmacol Sci 29: 346-351, 2008.
17. Bhagwat SV, Mullick J, Avadhani NG, and Raza H. Differential response of cytosolic, microsomal, and mitochondrial glutathione S-transferases to xenobiotic inducers. Int J Oncol 13: 281-288, 1998. (Pubitemid 28329216)
18. Blair IA. Endogenous glutathione adducts. Curr Drug Metab 7: 853-872, 2006. (Pubitemid 44873711)
19. Blais JD, Filipenko V, Bi M, Harding HP, Ron D, Koumenis C, Wouters BG, and Bell JC. Activating transcription factor 4 is translationally regulated by hypoxic stress. Mol Cell Biol 24: 7469-7482, 2004. (Pubitemid 39121475)
20. Blanc EM, Keller JN, Fernandez S, and Mattson MP. 4- Hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia 22: 159-160, 1998.
21. Blank V. Small Maf proteins in mammalian gene control: Mere dimerization partners or dynamic transcriptional regulators? J Mol Biol 376: 913-925, 2008.
22. Bloom DA and Jaiswal AK. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization=accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J Biol Chem 278: 44675-44682, 2003. (Pubitemid 37377224)
23. Borutaite V and Brown GC. Mitochondrial regulation of caspase activation by cytochrome oxidase and tetramethylphenylenediamine via cytosolic cytochrome C redox state. J Biol Chem 282: 31124-31130, 2007. (Pubitemid 350044866)
24. Brigelius-Flohe R. Tissue-specific functions of individual glutathione peroxidases. Free Rad Biol Med 27: 951-965, 1999. (Pubitemid 29507469)
25. Burdo J, Dargusch R, and Schubert D. Distribution of the cystine=glutamate antiporter system Xc- in the brain, kidney and duodenum. J Histochem Cytochem 54: 549-557, 2006.
26. Canals S, Casarejos MJ, de Bernardo S, Rodriguez-Martin E, and Mena MA. Nitric oxide triggers the toxicity due to glutathione depletion in midbrain cultures through 12- lipoxygenase. J Biol Chem 278: 21542-21549, 2003. (Pubitemid 36792552)
27. Cantero A-V, Portero-Otin M, Ayala V, Auge N, Sanson M, Elbaz M, Thiers JC, Pamplona R, Salvayre R, and Negre-Salvayre A. Methylglyoxal induces advanced glycation end protein (AGEs) formation and dysfunction of PDGF receptor-b: Implications for diabetic atherosclerosis. FASEB J 21: 3096-3106, 2007. (Pubitemid 47565530)
28. Chauhan A and Chauhan V. Oxidative stress in autism. Pathophysiology 13: 171-181, 2006.
29. Chen C and Kong ANT. Dietary chemopreventive compounds and ARE=EpRE signaling. Free Rad Biol Med 36: 1505-1516, 2004. (Pubitemid 38746559)
30. Chen P-C, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, and Johnson JA. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte. Proc Natl Acad Sci USA 106: 2933- 2938, 2009.
31. Chen W, Sun Z, Wang X-J, Jiang T, Huang Z, Fang D, and Zhang DD. Direct interaction between Nrf2 and p21Cip1/WAF1 upregulates the Nrf2-mediated antioxidant response. Mol Cell 34: 663-673, 2009.
32. Chiarugi P and Buricchi F. Protein tyrosine phosphorylation and reversible oxidation: Two cross-talking posttranslational modifications. Antioxid Redox Signal 9: 1-24, 2007. (Pubitemid 44910992)
33. Christensen HN. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 70: 43-77, 1990. (Pubitemid 20037281)
34. Clements CM, McNally RS, Conti BJ, Mak TW, and Ting JPY. DJ-1, a cancer and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA 103: 15091-15096, 2006. (Pubitemid 44583169)
35. Costa-Mattioli M, Gobert D, Stern E, Gamache K, Colina R, Cuello C, Sossin W, Kaufman RJ, Pelletier J, Rosenblum K, Krnjevic K, Lacaille JC, Nader K, and Sonenberg N. eIF2alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory. Cell 129: 195-206, 2007. (Pubitemid 46507591)
36. Crack PJ, Taylor JM, Flentjar NJ, de Haan J, Hertzog P, Iannello RC, and Kola I. Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (Gpx-1) knockout mouse brain in response to ischemia=reperfusion injury. J Neurochem 78: 1389-1399, 2001. (Pubitemid 32899770)
37. Cullinan SB and Diehl JA. Coordination of ER and oxidative stress signaling: The PERK=Nrf2 signaling pathway. Int J Biochem Cell Biol 38: 317-332, 2006. (Pubitemid 41821881)
38. Dalle-Donne I, Rossi R, Colombo G, Giustarini D, and Milzani A. Protein S-glutathionylation: A regulatory device from bacteria to humans. Trends Biochem Sci 34: 85-96, 2009.
39. Dalton TP, Chen Y, Schneider SN, Nebert DW, and Shertzer HG. Genetically altered mice to evaluate glutathione homeostasis in health and disease. Free Rad Biol Med 37: 1511-1526, 2004. (Pubitemid 39349798)
40. de Vries HE, Witte M, Hondius D, Rozemuller AJM, Drukarch B, Hoozemans J, and van Horssen J. Nrf2-induced antioxidant protection: A promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Rad Biol Med 45: 1375-1383, 2008.
41. DeGracia DJ, Kumar R, Owen CR, Krause GS, and White BC. Molecular pathways of protein synthesis inhibition during brain reperfusion: Implications for neuronal survival or death. J Cereb Blood Flow Metab 22: 127-141, 2002. (Pubitemid 34135644)
42. Dhakshinamoorthy S, Jain AK, Bloom DA, and Jaiswal AK. Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J Biol Chem 280: 16891-16900, 2005. (Pubitemid 41389148)
43. Diaz-Hernandez JI, Almeida A, Delgado-Esteban M, Fernandez E, and Bolanos JP. Knockdown of glutamatecysteine ligase by small hairpin RNA reveals that both catalytic and modulatory subunits are essential for the survival of primary neurons. J Biol Chem 280: 38992-39001, 2005. (Pubitemid 41713849)
44. Dickinson DA and Forman HJ. Glutathione in defense and signaling. Ann NY Acad Sci 973: 488-504, 2002.
45. Dickinson DA, Levonen A-L, Moellering DR, Arnold EK, Zhang H, Darley-Usmar VM, and Forman HJ. Human glutamate cysteine ligase gene regulation through the electrophile response element. Free Rad Biol Med 37: 1152-1159, 2004. (Pubitemid 39296740)
46. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, and Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 99: 11908-11913, 2002. (Pubitemid 34994497)
47. Dringen R. Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal 7: 1223-1233, 2005. (Pubitemid 41232519)
48. Dringen R, Hamprecht B, and Broer S. The peptide transporter PepT2 mediates the uptake of the glutathione precursor CysGly in astroglia-rich primary cultures. J Neurochem 71: 388-393, 1998. (Pubitemid 28292572)
49. Dringen R and Hirrlinger J. Glutathione pathways in the brain. Biol Chem 384: 505-516, 2003. (Pubitemid 36609167)
50. Esposito LA, Kokoska JE, Waymire KG, Cottrell B, Mac- Gregor GR, and Wallace DC. Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene. Free Rad Biol Med 28: 754-776, 2000.
51. Fogal B, Li J, Lobner D, McCullough LD, and Hewett SJ. System Xc- activity and astrocytes are necessary for interleukin- 1b-mediated hypoxic neuronal injury. J Neurosci 27: 10094-10105, 2007. (Pubitemid 47450471)
52. Garber K. A mid-life crisis for aging theory. Nature Biotechnol 26: 371-374, 2008. (Pubitemid 351501795)
53. Garden GA and Moller T. Microglia biology in health and disease. J Neuroimmune Pharmacol 1: 127-137, 2006. (Pubitemid 44257488)
54. Garnier R, Rambourg-Schepens MO, Muller A, and Hallier E. Glutathione transferase activity and formation of macromolecular adducts in two cases of acute methyl bromide poisoning. Occup Environ Med 53: 211-215, 1996. (Pubitemid 26101871)
55. Gietzen DW, Ross CM, Hao S, and Sharp JW. Phosphorylation of eIF2alpha is involved in the signaling of indispensable amino acid deficiency in the anterior piriform cortex of the brain of rats. J Nutr 134: 717-723, 2004. (Pubitemid 38456234)
56. Gilbert HF. 1Redox control of enzyme activities by thiol= disulfide exchange. Methods Enzymol 107: 330-351, 1984. (Pubitemid 14053814)
57. Gopalakrishna R, Gundimeda U, Schiffman JE, and McNeill TH. A direct redox regulation of protein kinase C isoenzymes mediates oxidant-induced neuritogenesis in PC12 cells. J Biol Chem 283: 14430-14444, 2008.
58. Grallert B and Boye E. The Gcn2 kinase as a cell cycle regulator. Cell Cycle 6: 2768-2772, 2007. (Pubitemid 350277168)
59. Grubisha O, Smith BC, and Denu JM. Small molecule regulation of Sir2 protein deacetylases. FEBS J 272: 4607-4616, 2005. (Pubitemid 41366985)
60. Gutscher M, Pauleau A-L, Marty L, Brach T, Wabnitz GH, Samstag Y, Meyer AJ, and Dick TP. Real-time imaging of the intracellular glutathione redox potential. Nature Methods 5: 553-559, 2008. (Pubitemid 351761764)
61. Hai T and Curran T. Cross family dimerization of transcription factors Fos=Jun and ATF=CREB alters DNA binding specificity. Proc Natl Acad Sci USA 88: 3720-3724, 1991. (Pubitemid 21916695)
62. Halliwell B and Gutteridge JMC. Free Radicals in Biology and Medicine. Oxford, New York, 1993.
63. Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, and Ron D. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6: 1099-1108, 2000.
64. Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, Sadri N, Yun C, Popko B, Paules R, Stojdl DF, Bell JC, Hettmann T, Leiden JM, and Ron D. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 11: 619-633, 2003. (Pubitemid 36385118)
65. Harvey CJ, Thimmulappa RK, Singh A, Blake DJ, Ling G, Wakabayashi N, Fujii J, Myers A, and Biswal S. Nrf2- regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Rad Biol Med 46: 443-453, 2009.
66. Hayes JD, Ellis EM, Neal GE, Harrison DJ, and Manson MM. Cellular response to cancer chemopreventive agents: Contribution of the antioxidant responsive element to the adaptive response to oxidative and chemical stress. Biochem Soc Symp 64: 141-168, 1999. (Pubitemid 129602115)
67. Hayes JD and McLellan LI. Glutathione and glutathionedependent enzymes represent a coordinately regulated defence against oxidative stress. Free Rad Res 31: 273-300, 1999. (Pubitemid 29452854)
68. He CH, Gong P, Hu B, Stewart D, Choi ME, Choi AMK, and Alam J. Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. J Biol Chem 276: 20858-20865, 2001.
69. Hertel M, Braun S, Durka S, Alzheimer C, and Werner S. Upregulation and activation of the Nrf-1 transcription factor in the lesioned hippocampus. Eur J Neurosci 15: 1707-1711, 2002. (Pubitemid 35471926)
70. Hisahara S, Chiba S, Matsumoto H, Tanno M, Yagi H, Shimohama S, Sato M, and Horio Y. Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation. Proc Natl Acad Sci USA 105: 15599-15604, 2008.
71. Hogg N, Singh RJ, and Kalyanaraman B. The role of glutathione in the transport and catabolism of nitric oxide. FEBS Lett 382: 223-228, 1996. (Pubitemid 26091436)
72. Hogg N, Singh RJ, Konorev E, Joseph J, and Kalyanaraman B. S-Nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase. Biochem J 323: 477-481, 1997.
73. Huang H-C, Nguyen T, and Pickett CB. 2Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 277: 42769-42774, 2002. (Pubitemid 35285650)
74. Huang J and Philbert MA. Distribution of glutathione and glutathione-related enzyme systems in mitochondria and cytosol of cultured cerebellar astrocytes and granule cells. Brain Res 680: 16-22, 1995.
75. Hubbs AF, Benkovic SA, Miller DB, O'Callaghan JP, Battelli L, Schwegler-Berry D, and Ma Q. Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2. Am J Pathol 170: 2068-2076, 2007. (Pubitemid 47339279)
76. Hussain SG and Ramaiah KVA. Reduced eIF2alpha phosphorylation and increased proapoptotic proteins in aging. Biochem Biophys Res Commun 355: 365-370, 2007. (Pubitemid 46282638)
77. Igarashi T, Izumi H, Uchiumi T, Nishio K, Arao T, Tanabe M, Uramoto H, Sugio K, Yasumoto K, Sasaguri Y, Wang KY, Otsuji Y, and Kohno K. Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines. Oncogene 26: 4749-4760, 2007. (Pubitemid 47093179)
78. Innamorato NG, Rojo AI, Garcia-Yague AJ, Yamamoto M, de Ceballos ML, and Cuadrado A. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol 181: 680-689, 2008.
79. Jain AK and Jaiswal AK. GSK-3b acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem 282: 16502-16510, 2007. (Pubitemid 47100395)
80. Jain AK and Jaiswal AK. Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J Biol Chem 281: 12132-12142, 2006. (Pubitemid 43855477)
81. Jensen DE, Belka GK, and DuBois GC. S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme. Biochem J 331: 659-668, 1998. (Pubitemid 28182185)
82. Jiang D, Akopian G, Ho Y-S, Walsh JP, and Andersen JK. Chronic brain oxidation in a glutathione peroxidase knockout mouse model results in increased resistance to induced epileptic seizures. Exper Neurol 164: 257-268, 2000. (Pubitemid 32008971)
83. Jones DP. Redox potential of GSH=GSSG couple: Assay and biological significance. Methods Enzymol 348: 93-112, 2002. (Pubitemid 41103102)
84. Josch C, Klotz LO, and Sies H. 2003. Identification of cytosolic leucyl aminopeptidase (EC 34.11.1) as the major cysteinylglycine-hydrolysing activity in rat liver. Biol Chem 384: 213-218, 2003. (Pubitemid 36348320)
85. Jousse C, Oyadomari S, Novoa I, Lu P, Zhang Y, Harding HP, and Ron D. Inhibition of a constitutive translation initiation 2alpha phosphatase, CReP, promotes survival of stressed cells. J Cell Biol 163: 767-775, 2003. (Pubitemid 37517884)
86. Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, Napper A, Curtis R, DiStefano PS, Fields S, Bedalov A, and Kennedy BK. Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 280: 17038-17045, 2005. (Pubitemid 41389166)
87. Kamata H, Oka S-I, Shibukawa Y, Kakuta J, and Hirata H. Redox regulation of nerve growth factor-induced neuronal differentiation of PC12 cells through modulation of the nerve growth factor receptor, TrkA. Arch Biochem Biophys 434: 16-25, 2005. (Pubitemid 40040466)
88. Kanai Y and Hediger MA. The glutamate=neutral amino acid transporter family SLC1: Molecular, physiological and pharmacological aspects. Pflugers Arch 447: 469-479, 2004. (Pubitemid 38241433)
89. Kato Y, Koike Y, Tomizawa K, Ogawa S, Hosaka K, Tanaka S, and Kato T. Presence of activating transcription factor 4 (ATF4) in the porcine anterior pituitary. Mol Cell Endocrin 154: 151-159, 1999. (Pubitemid 29387339)
90. Kemp M, Go Y-M, and Jones DP. Nonequilibrium thermodynamics of thiol=disulfide redox systems: A perspective on redox systems biology. Free Rad Biol Med 44: 921-937, 2008.
91. Kensler TW, Wakabayashi N, and Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2- ARE pathway. Annu Rev Pharmacol Toxicol 47: 89-116, 2007.
92. Keum Y-S, Yu S, Chang PP-J, Yuan X, Kim J-H, Xu C, Han J, Agarwal A, and Kong A-NT. Mechanism of action of sulforaphane: Inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells. Cancer Res 66: 8804-8813, 2006. (Pubitemid 44449198)
93. Klivenyi P, Andreassen OA, Ferrante RJ, Dedeoglu A, Mueller G, Lancelot, BogdanovM, Andersen JK, Jiang D, and Beal MF. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. J Neurosci 20: 1-7, 2000. (Pubitemid 30220485)
94. Knott AB and Bossy-Wetzel E. Nitric oxide in health and disease of the nervous system. Antioxid Redox Signal 11: 541-554, 2009.
95. Kobayashi M, Li L, Iwamoto N, Nakajima-Takagi Y, Kaneko H, Nakayama Y, Eguchi M, Wada Y, Kumagai Y, and Yamamoto M. The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol Cell Biol 29: 493-502, 2009.
96. Koditz J, Nesper J, Wottawa M, Stiehl DP, Camenisch G, Franke C, Myllyharju J, Wenger RH, and Katchinski DM. Oxygen-dependent ATF 4 stability is mediated by the PHD3 oxygen sensor. Blood 110: 3610-3617, 2007. (Pubitemid 350159628)
97. Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y, Iemura S, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, and Yamamoto M. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12: 213-223, 2010.
98. Kraft AD, Johnson DA, and Johnson JA. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 24: 1101-1112, 2004. (Pubitemid 38177017)
99. Kuhla B, Boeck K, Luth H-J, Schmidt A, Weigle B, Schmitz M, Ogunlade V, Munch G, and Arendt T. Age-dependent changes of glyoxylase I expression in human brain. Neurobiol Aging 27: 815-822, 2006.
100. Kumar R, Azam S, Sullivan JM, Owen C, Cavener DR, Zhang P, Ron D, Harding HP, Chen J-J, Han A, White BC, Krause GS, and DeGracia DJ. Brain ischemia and reperfusion activates the eukaryotic initiation factor 2a kinase, PERK. J Neurochem 77: 1418-1421, 2001. (Pubitemid 32523694)
101. Kumar R, Krause GS, Yoshida H, Mori K, and DeGracia DJ. Dysfunction of the unfolded protein response during global brain ischemia and reperfusion. J Cereb Blood Flow Metab 23: 462-471, 2003. (Pubitemid 36403028)
102. Lassot I, Estrabaud E, Emiliani S, Benkirane M, Benarous R, and Margottin-Goguet F. p300 modulates ATF4 stability and transcriptional activity independently of its acetyltransferase domain. J Biol Chem 280: 41537-41545, 2005. (Pubitemid 41832215)
103. Lassot I, Segeral E, Berlioz-Torrent C, Durand H, Groussin L, Hai T, Benarous R, and Margottin-Goguet F. ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligase. Mol Cell Biol. 21: 2192-2202, 2001. (Pubitemid 32479639)
104. Lavoie S, Chen Y, Dalton TP, Gysin R, Cuenod M, Steullet P, and Do KQ. Curcumin, quercetin and tBHQ modulate glutathione levels in astrocytes and neurons: Importance of the glutamate cysteine ligase modifier subunit. J Neurochem 108: 1410-1422, 2009.
105. Lee J-M, Hanson JM, Chu WA, and Johnson JA. Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells. J Biol Chem 276: 20011-20016, 2001.
106. Lee J-M, Shih AY, Murphy TH, and Johnson TH. NF-E2- related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J Biol Chem 278: 37948-37956, 2003. (Pubitemid 37175325)
107. Leslie NR. The redox regulation of PI 3-kinase-dependent signaling. Antioxid Redox Signal 8: 1765-1774, 2006. (Pubitemid 44726350)
108. Lewerenz J, Dargusch R, and Maher P. Lactacidosis modulates glutathione metabolism and oxidative glutamate toxicity. J Neurochem 113: 502-514, 2010.
109. Lewerenz J, Klein M, and Methner A. Cooperative action of glutamate transporters and cystine=glutamate antiporter system Xc- protects from oxidative glutamate toxicity. J Neurochem 98: 916-925, 2006. (Pubitemid 44051291)
110. Lewerenz J and Maher P. Basal levels of eIF2a phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. J Biol Chem 284: 1106-1115, 2009.
111. Li J, Lee J-M, and Johnson JA. Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stressinduced apoptosis in IMR-32 cells. J Biol Chem 277: 388-394, 2002. (Pubitemid 34952070)
112. Li S and Whorton AR. Identification of stereoselective transporters for S-nitroso-L-cysteine: Role of LAT1 and LAT2 in biological activity of S-nitrosothiols. J Biol Chem 280: 21201-20110, 2005.
113. Li W and Kong A-N. Molecular mechanisms of Nrf2- mediated antioxidant response. Mol Carcinogen 48: 91-104, 2009.
114. Li Y, Maher P, and Schubert D. A role of 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19: 453-463, 1997. (Pubitemid 27374242)
115. Li Z, Dong T, Proschel C, and Noble M. Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function. PLoS Biol 5: 212-231, 2007.
116. Lin JH, Li H, Yasumura D, Cohen HR, Zhang C, Panning B, Shokat KM, Lavail MM, and Walter P. IRE1 signaling affects cell fate during the unfolded protein response. Science 318: 944-949, 2007. (Pubitemid 350098984)
117. Liu L, Hausladen A, Zeng M, Que L, Heitman J, and Stamler JS. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 410: 490-494, 2001. (Pubitemid 32240051)
118. Lu PD, Jousse C, Marciniak SJ, Zhang Y, Novoa I, Scheuner D, Kaufman RJ, Ron D, and Harding HP. Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2. EMBO J 23: 169-179, 2004. (Pubitemid 38165757)
119. Lu SC. Regulation of glutathione synthesis. Mol Aspects Med 30: 42-59, 2009.
120. Maher P. Redox control of neural function: Background, mechanisms and significance. Antioxid Redox Signal 8: 1941-1970, 2006. (Pubitemid 46489624)
121. Maher P. The effects of stress and aging on glutathione metabolism. Ageing Res Rev 4: 288-314, 2005. (Pubitemid 41114862)
122. Malmberg SE and Adams CM. Insulin signaling and the general amino acid control response: Two distinct pathways to amino acid synthesis and uptake. J Biol Chem 283: 19229-19234, 2008.
123. Mandeles S and Block K. Enzymatic synthesis of gamma glutamylcysteine. J Biol Chem 214: 639-646, 1955.
124. Mattson MP. Roles of lipid peroxidation product 4- hydorxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol 44: 625-633, 2009.
125. Meister A and Anderson ME. Glutathione. Ann Rev Biochem 52: 711-760, 1983. (Pubitemid 13030692)
126. Mieyal JJ, Gallogly MM, Qanungo S, Sabens EA, and Shelton MD. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal 10: 1941-1988, 2008.
127. Miller VM, Lawrence DA, Mondal TK, and Seegal RF. Reduced glutathione is highly expressed in white matter and neurons in the unperturbed mouse brain. Implications for oxidative stress associated with neurodegeneration. Brain Res 1276: 22-30, 2009.
128. Minich T, Riemer J, Schulz JB, Wielinga P, Wijnholds J, and Dringen R. The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes. J Neurochem 97: 373-384, 2006.
129. Miralles VJ, Martinez-Lopez I, Zaragoza R, Borras E, Garcia C, Pallardo FV, and Vina JR. Na\+ dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) in primary astrocyte cultures: Effect of oxidative stress. Brain Res 922: 21-29, 2001. (Pubitemid 33152841)
130. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, and Coyle JT. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2: 1547-1558, 1989.
131. Nguyen T, Nioi P, and Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284: 13291-13295, 2009.
132. Nguyen T, Sherratt PJ, and Pickett CB. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 43: 233-260, 2003. (Pubitemid 37372641)
133. Nikitovic D and Holmgren A. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J Biol Chem 271: 19180-19185, 1996. (Pubitemid 26271582)
134. Noble M, Smith J, Power J, and Mayer-Proschel M. Redox state as a central modulator of precursor cell function. Ann NY Acad Sci 991: 251-271, 2003. (Pubitemid 36793819)
135. Novoa I, Zeng H, Harding HP, and Ron D. Feedback inhibition of the unfolded protein response by GADD34- mediated dephosphorylation of eIF2a. J Cell Biol 153: 1011-1021, 2001. (Pubitemid 34289240)
136. Pacholec M, Chrunyk B, Cunningham D, Flynn D, Griffith D, Griffor M, Loulakis P, Pabst B, Qiu X, Stockman B, Thanabal V, Varghese A, Ward J, Withka J, and Ahn K. SRT1720, SRT2183, SRT1460 and resveratrol are not direct activators of Sirt1. J Biol Chem 285: 8340-8351, 2010.
137. Pang L, Sawada T, Decker SJ, and Saltiel AR. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270: 13585-13588, 1995.
138. Park H-A, Khanna S, Rink C, Gnyawali S, Roy S, and Sen CK. Glutathione disulfide induces neural cell death via a 12-lipoxygenase pathway. Cell Death Differ 16: 1167-1179, 2009.
139. Paschen W, Mengesdorf T, Althausen S, and Hotop S. Peroxidative stress selectively down-regulates the neuronal stress response activated under conditions of endoplasmic reticulum dysfunction. J Neurochem 76: 1916-1924, 2001. (Pubitemid 32221132)
140. Patel R, McIntosh L, McLaughlin J, Brooke S, Nimon V, and Sapolsky R. Disruptive effect of glucocorticoids on glutathione peroxidase biochemistry in hippocampal cultures. J Neurochem 82: 118-125, 2002. (Pubitemid 34755256)
141. Paupe V, Dassa EP, Goncalves S, Auchere F, Lonn M, Holmgren A, and Rustin P. Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia. PLOS One 4: e4253, 2009.
142. Pawate S, Shen Q, Fan F, and Bhat NR. Redox regulation of glial inflammatory response to lipopolysaccharide and interferong. J Neurosci Res 77: 540-551, 2004. (Pubitemid 39007006)
143. Phillis JW, Horrocks LA, and Farooqui AA. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: Their role and involvement in neurological disorders. Brain Res Rev 52: 201-243, 2006. (Pubitemid 44291802)
144. Podust LM, Krezel AM, and Kim Y. Crystal structure of the CCAAT box=enhancer-binding protein beta activating transcription factor-4 basic leucine zipper heterodimer in the absence of DNA. J Biol Chem 276: 505-513, 2001. (Pubitemid 32050344)
145. Proud CG. eIF2 and the control of cell physiology. Sem Cell Dev Biol 16: 3-12, 2005. (Pubitemid 40126871)
146. Prozorovski T, Schulze-Topphoff U, Glumm R, Baumgart J, Schroter F, Ninnemann O, Siegart E, Bendix I, Brustle O, Nitsch R, Zipp F, and Aktas O. Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nature Cell Biol 10: 385-394, 2008.
147. Ran Q, Gu M, Van Remmen H, Strong R, Roberts JL, and Richardson A. Glutathione peroxidase 4 protects cortical neurons from oxidative injury and amyloid toxicity. J Neurosci Res 84: 202-208, 2006 (Pubitemid 44023075)
148. Rebrin I, Kamzalov S, and Sohal RS. Effects of age and caloric restriction on glutathione redox status in mice. Free Rad Biol Med 35: 626-635, 2003. (Pubitemid 37101130)
149. Rinaldi, R, Eliasson E, Swedmark S, and Morgenstern R. Reactive intermediates and the dynamics of glutathione transferases. Drug Metab Dispo 30: 1053-1058, 2002.
150. Rock RB and Peterson PK. Microglia as a pharmacological target in infectious and inflammatory diseases on the brain. J Neuroimmune Pharmacol 1: 117-126, 2006. (Pubitemid 44257487)
151. Rojo AI, de Sagarra MR, and Cuadrado A. GSK-3b downregulates the transcription factor Nrf2 after oxidant damage: Relevance to exposure of neuronal cells to oxidative stress. J Neurochem 105: 192-202, 2009. (Pubitemid 351441636)
152. Romero JM and Bizzozero OA. Intracellular glutathione mediates the denitrosylation of protein nitrosothiols in the rat spinal cord. J Neurosci Res 87: 701-709, 2009.
153. Roy A, Jana A, Yatish K, Freidt MB, Fung YK, Martinson JA, and Pahan K. Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: Implications for neurodegenerative diseases. Free Rad Biol Med 45: 686-699, 2008.
154. Salazar M, Rojo AI, Velasco D, de Sagarra RM, and Cuadrado A. Glycogen synthase kinase-3b inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem 281: 14841-14851, 2006. (Pubitemid 43855189)
155. Sankaranarayanan K and Jaiswal AK. Nrf3 negatively regulates antioxidant-response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. J Biol Chem 279: 50810-50817, 2004. (Pubitemid 40017819)
156. Sato H, Shiiya A, Kimata M, Maebara K, Tamba M, Sakakura Y, Makino N, Sugiyama F, Yagami K, Moriguchi T, Takahashi S, and Bannai S. Redox imbalance in cystine= glutamate transporter-deficient mice. J Biol Chem 280: 37423-37429, 2005. (Pubitemid 41642349)
157. Schafer FQ and Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide=glutathione couple. Free Rad Biol Med 30: 1191-1212, 2001. (Pubitemid 32463931)
158. Scheuner D, Song B, McEwan E, Liu C, Laybutt R, Gillespie P, Saunders T, Bonner-Weir S, and Kaufman RJ. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol Cell 7: 1165-1176, 2001. (Pubitemid 32607351)
159. Scheuner D, Van der Mierde D, Song B, Flamez D, Creemers JW, Tsukamoto K, Ribick M, Schuit FC, and Kaufman RJ. Control of mRNA translation preserves endoplasmic reticulum function in beta cells and maintains glucose homeostasis. Nat Med 11: 757-764, 2005. (Pubitemid 41021208)
160. Schulz JB, Lindenau J, Seyfried J, and Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267: 4904-4911, 2000. (Pubitemid 30641286)
161. Seiler A, Schneider M, Forster H, SRoth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Radmark O, Wurst W, Bornkamm GW, Schweizer U, and Conrad M. Glutathione peroxidase 4 senses and translates oxidative stress into 12=15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab 8: 237-248, 2008.
162. Shih AY, Erb H, Sun X, Toda S, Kalivas P, and Murphy TH. Cystine=glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci 26: 10514-10523, 2006. (Pubitemid 44564602)
163. Shih AY, Imbeault S, Barakauskas V, Erb H, Jiang L, Li P, and Murphy TH. Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J Biol Chem 280: 22925-22936, 2005. (Pubitemid 40853201)
164. Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H, Johnson JA, and Murphy TH. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons fromoxidative stress. J Neurosci 23: 3394-3406, 2003. (Pubitemid 36531981)
165. Shih AY, Li P, and Murphy TH. A small molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J Neurosci 25: 10321-10335, 2005. (Pubitemid 41636229)
166. Snoke JE, Yanari S, and Bloch K. Synthesis of glutathione from gamma-glutamylcysteine. J Biol Chem 201: 573-586, 1953.
167. Soderdahl T, Enoksson M, Lundberg M, Holmgren A, Ottersen OP, Orrenius S, Bolcsfoldi G, and Cotgreave IA. Visualization of the compartmentalization of glutathione and protein-glutathione mixed disulfides in cultured cells. FASEB J 17: 124-126, 2003.
168. Sokka A-L, Putkonen N, Mudo G, Pryazhnikov E, Reijonen S, Khiroug L, Belluardo N, Lindholm D, and Korhonen L. Endoplasmic reticulum stress inhibition protects against excitotoxic neuronal injury in the rat brain. J Neurosci 27: 901-908, 2007. (Pubitemid 46174511)
169. Soltaninassab SR, Sekhar KR, Meredith MJ, and Freeman ML. Multi-faceted regulation of g-glutamylcystein synthetase. J Cell Physiol 183: 163-170, 2000.
170. Sontheimer H. Malignant gliomas: Perverting glutamate and ion homeostasis for selective advantage. Trends Neurosci 26: 543-549, 2003. (Pubitemid 37176909)
171. Sun X, Erb H, and Murphy TH. Coordinate regulation of glutathione metabolism in astrocytes by Nrf2. Biochem Biophys Res Commun 326: 371-377, 2005. (Pubitemid 39593557)
172. Tan S, Schubert D, and Maher P. Oxytosis: A novel form of programmed cell death. Curr Top Med Chem 1: 497-506, 2001.
173. Tan S, Somia N, Maher P, and Schubert P. Regulation of antioxidant metabolism by translation initiation factor 2a. J Cell Biol 152: 997-1006, 2001. (Pubitemid 34286075)
174. Tate SS and Meister A. gamma-Glutamyl transpeptidase: Catalytic, structural and functional aspects. Mol Cell Biochem 39: 357-368, 1981.
175. Taylor JM, Ali U, Iannello RC, Hertzog P, and Crack PJ. Diminished Akt phosphorylation in neurons lacking glutathione peroxidase-1 (Gpx1) leads to increased susceptibility to oxidative stress-induced death. J Neurochem 92: 283-293, 2005. (Pubitemid 40194019)
176. Thien CBF and Langdon WY. Cbl: Many adaptations to regulate protein tyrosine kinases. Nature Rev Mol Cell Biol 2: 294-305, 2001. (Pubitemid 33676972)
177. Thiruchelvam M, Prokopenko O, Cory-Slechta DA, Richfield EK, Buckley B, and Mirochnitchenko O. Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat \+ maneb-induced Parkinson's disease phenotype. J Biol Chem 280: 22530-22539, 2005. (Pubitemid 40827911)
178. Thornalley PJ. Glyoxylase I-structure, function and a critical role in the enzymatic defense against glycation. Biochem Soc Trans 31: 1343-1348, 2003. (Pubitemid 38030973)
179. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal Biochem 106: 207-212, 1969.
180. Townsend DM and Tew KD. The role of glutathione- S-transferase in anti-cancer drug resistance. Oncogene 22: 7369-7375, 2003.
181. Townsend DM, Tew KD, and Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 57: 145-155, 2003. (Pubitemid 36740460)
182. Vallejo M, Ron D, Miller CP, and Habener JF. C=ATF, a member of the activating transcription factor family of DNA binding proteins, dimerizes with CAAT=enhnacer binding proteins and directs their binding to cAMP response elements. Proc Natl Acad Sci USA 90: 4679-4683, 1993. (Pubitemid 23148969)
183. Vargas MR, Johnson DA, Sirkis DW, Messing A, and Johnson DA. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci 28: 13574-13581, 2008.
184. Vaughn AE and Deshmukh M. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome C. Nature Cell Biol 10: 1477-1483, 2008.
185. Verry F, Closs EI, Wagner CA, Palacin M, Endou H, and Kanai Y. CATs and HATs: The SLC7 family of amino acid transporters. Pflugers Arch 447: 532-542, 2004. (Pubitemid 38258215)
186. Vinson CR, Hai T, and Boyd SM. Dimerization specificity of the leucine zipper-containing bZIP motif on DNA binding: Prediction and rational design. Gene Develop 7: 1047-1058, 1993. (Pubitemid 23170828)
187. Waak J and Dringen R. Formation and rapid export of the monochlorobimane-glutathione conjugate in cultured rat astrocytes. Neurochem Res 31: 1409-1416, 2006. (Pubitemid 44900580)
188. Wagner CA, Lang F, and Broer S. Function and structure of heterodimeric amino acid transporters. Am J Physiol Cell Physiol 281: C1077-C1093, 2001.
189. Wang H, Li J, Follett PL, Zhang Y, Cotanche DA, Jensen FE, Volpe JJ, and Rosenberg PA. 12-Lipoxygenase plays a key role in cell death caused by glutathione depletion and arachidonic acid in rat oligodendrocytes. Eur J Neurosci 20: 2049-2058, 2004. (Pubitemid 39331125)
190. Wang XF and Cynader MS. Astrocytes provide cysteine to neurons by releasing glutathione. J Neurochem 74: 1434-1442, 2000. (Pubitemid 30163963)
191. Wek RC, Jiang H-Y, and Anthony TG. Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans 34: 7-11, 2006. (Pubitemid 43235522)
192. Xu C, Yuan X, Pan Z, Shen G, Kim J-H, Yu S, Khor TO, Li W, Ma J, and Kong A-NT. Mechanism of action of isothiocyanates: The induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2. Mol Cancer Ther 5: 1918-1926, 2006. (Pubitemid 44336562)
193. Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, Hanauer A, and Karsenty G. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; Implication for Coffin-Lowry syndrome. Cell 117: 387-398, 2004. (Pubitemid 38534544)
194. Yant LJ, Ran Q, Rao L, Van Remmen H, Shibatani T, Belter JG, Motta L, Richardson A, and Prolla TA. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Rad Biol Med 34: 496-502, 2003. (Pubitemid 36140174)
195. Ying W, Han SK, Miller JW, and Swanson RA. Acidosis potentiates oxidative neuronal death by multiple mechanisms. J Neurochem 73: 1549-1556, 1999. (Pubitemid 29440156)
196. Yu R, Lei W, Mandlekar S, Weber MJ, Der CJ, Wu J, and Kong A-NT. Role of mitogen activated protein kinase pathway in the induction of Phase II detoxifying enzymes by chemicals. J Biol Chem 274: 27545-27552, 1999.
197. Yu R, Mandlekar S, Lei W, Fahl WE, Tan T-H, and Kong A-NT. p38 mitogen activated protein kinase negatively regulates the induction of Phase II drug-metabolizing enzymes that detoxify carcinogens. J Biol Chem 275: 2322-2327, 2000. (Pubitemid 30081988)
198. Zeevalk GD, Razmpour R, and Bernard LP. Glutathione and Parkinson's disease: Is this the elephant in the room? Biomed Pharmacother 62: 236-249, 2008. (Pubitemid 351626446)
199. Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 38: 769-789, 2006. (Pubitemid 44903268)
200. Zhao J, Moore AN, Redell JB, and Dash PK. Enhancing expression of Nrf2-driven genes protects the blood-brain barrier after brain injury. J Neurosci 27: 10240-10248, 2007. (Pubitemid 47450456)
201. Zhao Y, Seefeldt T, Chen W, Wang X, Metthees D, Hu Y, and Guan X. Effects of glutathione reductase inhibition on cellular thiol redox state and related systems. Arch Biochem Biophys 485: 56-62, 2009.
202. Zimmerman AK, Loucks FA, Schroeder EK, Bouchard RJ, Tyler KL, and Linseman DA. Glutathione binding to the Bcl-2 homology-3 domain groove. J Biol Chem 282: 29296-29304, 2007.